phase readout
saveNCT07006012: RGL-305+ Lymphoma + Exploratory Clinical Study
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Fudan University. Phase: NA. Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
view source ↗
comments(0)
5-min edit window · permanent after that